REVOLUTIONARY advances in stroke treatment are dramatically improving patient outcomes, offering new hope for patients and ...

Discover the critical elements that influence stroke recovery outcomes, from timing of treatment to rehabilitation approaches ...

Researchers at UT Southwestern Medical Center found that tenecteplase, a newer drug, is just as safe and effective as ...

Coinciding with the FDA’s clearance for the catheter, Perfuze has also completed a €22m ($24m) financing round.

MicroTransponder has received $65m in a Series F financing round, which aims to enhance its stroke care offerings with the ...

Genentech’s label expansion for TNKase consolidates its market position for pharmacological stroke treatments.

Learn the key differences between stroke and migraine symptoms, from onset speed to pain patterns, and know exactly when to ...

With its FDA-approved neurostimulator implant aimed at helping patients recover from stroke, MicroTransponder has raised $65 ...

The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent.

In Alaska, where access to specialist care is challenging and emergency transfers can be harrowing, providers are using AI to ...

A report has warned that stroke victims are facing a postcode lottery to access lifesaving treatment. The Stroke Association ...